CasInvent Pharma raises €1.3M from KHAN-I and i&i Bio for the development of CK1 inhibitors for the treatment of cancers
With the funding, CasInvent Pharma will be strengthening its portfolio of CK1 inhibitors and progressing its lead compound to the development candidate status.
Source: einnews.com